Multiple Myeloma (cont.)
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- What is multiple myeloma?
- What causes multiple myeloma?
- What are risk factors for multiple myeloma?
- What are the signs and symptoms of multiple myeloma?
- How is multiple myeloma diagnosed?
- What are the stages of multiple myeloma?
- What is the treatment for multiple myeloma?
- What is the prognosis for multiple myeloma?
- What support systems are available for multiple myeloma?
- Find a local Oncologist in your town
What is the prognosis for multiple myeloma?
The prognosis of multiple myeloma is variable, depending on the approximate stage and response to therapy. However, there is no cure for the disease. For all patients the average 5-year survival rate is about 35%. Survival rates are higher in younger patients and lower in the elderly. Levels of C-reactive protein and beta-2 microglobulin have been used to predict survival times (for example, mean survival time in someone with both proteins levels less than 6 mg/L is 54 months and is 6 months if both are above 6 mg/L). Patients with tumor masses, kidney impairment, Bence Jones proteins, and elevated blood calcium (hypercalcemia) have a poor prognosis.
What support systems are available for multiple myeloma?
The International Myeloma Foundation (IMF) can provide caregivers and patients information about many aspects of this disease. IMF's phone number is 1-(800)-452-2873. There are local, state, and national support groups for multiple myeloma, but not all are available in every city.
"Multiple Myeloma." American Cancer Society. 12 Feb 2013.
"Multiple Myeloma Support Groups." The Myeloma Beacon.
"NCCN Guidelines." National Comprehensive Cancer Network.
Fanning, Suzanne R., et al. "Monoclonal gammopathies of uncertain origin." Medscape. 12 Jun 2013.
Viewers share their comments
Get the latest treatment options.